Abacavir, Lamivudine And Zidovudine Tablet
Product Images NDC 68180-286
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abacavir, Lamivudine And Zidovudine (NDC 68180-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lamivudine (E1e30726 5522 4214 B103 A016a08fdfcb 02)
Zidovudine (E1e30726 5522 4214 B103 A016a08fdfcb 03)
Ndc 68180-286-07abacavir Sulfate, Lamivudine And Zidovudine Tablets 300 mg 150 mg 300 mgtabletsrx Only Bottle Label: 60 Tablets (E1e30726 5522 4214 B103 A016a08fdfcb 04)
This is a medication called Zidovudine. It is a film-coated tablet containing abacavir sulfate, lamivudine, and zidovudine. The dosage information is not provided, so it is recommended to refer to the prescribing information. The medication should be stored within a certain temperature range and should be dispensed with a Medication Guide and Warning Card. This medication is manufactured by Lupin Limited in India and is supplied by Lupin Pharmaceuticals in the United States in a quantity of 60 tablets.*
Ndc 68180-286-07abacavir Sulfate, Lamivudine And Zidovudine Tablets 300 mg 150 mg 300 mgtabletsrx Only Carton Label: 60 Tablets (E1e30726 5522 4214 B103 A016a08fdfcb 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.